Learn how targeted therapy and molecular profiling are advancing personalized cancer treatment. Understand how genetic insights guide therapy decisions to improve outcomes.
HER2-positive breast cancer is a type in which the cancer cells make too much of a protein called human epidermal growth factor receptor 2. Learn more.
FCS Study Finds Comparable Quality and Safety Outcomes in CAR T-Cell Therapy Across Accredited and Non-Accredited Centers, Highlighting Care Location as Key Driver of Patient Access and Experience
Targeted Therapy and Molecular Profiling in Cancer CareLearn how targeted therapy and molecular profiling are advancing personalized cancer treatment. Understand how genetic insights guide therapy decisions to improve outcomes.
Rx To Go Achieves Accreditation with ACHCRx To Go achieves ACHC re-accreditation for pharmacy with distinction in oncology.
Therapeutic PhlebotomySome conditions cause your body to overproduce red blood cells or iron. A phlebotomy will remove some of these cells.
Triple Negative Breast Cancer -Summary, Symptoms, TreatmentsTriple-negative breast cancer lacks three common receptors found in many other breast cancers: estrogen, progesterone, and HER2 protein. Learn more.
Bone Marrow BiopsyBone marrow biopsy and bone marrow aspiration are procedures to collect and examine bone marrow. Learn More.
HER2-Positive Breast Cancer – Summary, Symptoms, TreatmentsHER2-positive breast cancer is a type in which the cancer cells make too much of a protein called human epidermal growth factor receptor 2. Learn more.
FCS Clinicians Offer Insights on Optimizing Patient Outcomes at Statewide CongressFCS clinicians share expertise at the FLASCO Fall Oncology Congress to advance cancer care and improve patient outcomes.
The Path of a Patient Sample – VideoIn this video John Sodeika discusses his journey to recovery after being diagnosed with advanced gastric cancer.